CORONA, Calif., Feb. 5 -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that the company expects to initiate shipments of alendronate sodium in ...

Please provide your email address to receive an email when new articles are posted on . Women who have ever used alendronate sodium may be at an increased risk of incident atrial fibrillation, ...

This drug had not previously been considered by the PBAC for this indication. Osteoporosis must be confirmed by the finding of low bone mass of at least 2 standard deviations below the gender specific ...

Sun Pharma announced a recall of Alendronate Sodium Tablets 70mg, the generic version of Fosamax. Sun Pharma announced a recall of Alendronate Sodium Tablets 70mg, the generic version of Merck‘s ...

BANGALORE, Sept 12 (Reuters) - India's Sun Pharmaceutical Industries said it has received approval from the U.S. Food and Drug Administration to market alendronate sodium tablets, the generic version ...

San Diego, CA (May 15, 2003) -- In a new analysis, gastrointestinal (GI)-related medical expenses for osteoporosis patients initiating therapy with Fosamax® (alendronate sodium tablets) were nearly ...

In the United States, 2 amino bisphosphonates -- alendronate and risedronate-- are currently approved for the prevention and treatment of osteoporosis. The primary clinical trials that provided ...

If alendronate 35 mg weekly is prescribed to maintain bone density, clinicians should also recommend supplemental calcium intake, such as 1,000–1,500 mg per day, and maintain serum vitamin 25OHD ...

April 14, 2005 -- The U.S. Food and Drug Administration (FDA) has approved mometasone furoate inhalation powder for the maintenance treatment of asthma as prophylactic therapy in patients aged 12 ...

NORTH WALES, Pa. Teva has announced the introduction and availability of alendronate sodium tablets. This is the generic version of the osteoporosis drug Fosamax by Merck. The drug will be available ...

A retrospective cohort study by compared different osteoporosis preventative-medications and found that selective estrogen receptor modulators (SERM) had better hip and major fracture risk reductions ...